Predict your next investment

cweil.com

See what CB Insights has to offer

Investments

1

Portfolio Exits

1

About Christopher Weil & Co.

CWC is a financial services firm with four major lines of business: Portfolio Management, Financial Planning, Private Equity and Asset Management Services. Christopher Weil formed the original CWC in 1971 as a NASD/SEC securities broker-dealer. Chris operated CWC and an affiliated real-estate investment firm until 1985, when he sold both to an affiliate of a New York Stock Exchange-listed company. Chris stayed on as chairman until 1988. In 1989, Chris formed The Weil Company (which in 1996 adopted Christopher Weil & Company, Inc. as its "dba") to continue the CWC investment-management business. Today, CWC and its affiliates-CWC Asset Advisors, Inc. and Storage Managers, Inc.-manage stock and bond portfolios, operate a number of private equity funds and provide an array of related financial and personal services.

Christopher Weil & Co. Headquarter Location

12555 High Bluff Drive Suite 180

92130,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Christopher Weil & Co. News

SD 500: Christopher Weil

Jan 17, 2018

The San Diego 500, The Book of Influential Business Leaders, is the market’s most comprehensive product of people you should know in the business community. The 500 includes business leaders and executives who have founded or are running significant companies in terms of number of jobs, key products and services, experts who raise the level of the industry here and beyond and those who lead in the business community. The 500 is selected by the San Diego Business Journal newsroom. Christopher Weil Chairman, Christopher Weil & Co. Inc. Weil formed the original CWC in March 1971 as an NASD/SEC securities broker-dealer and operated CWC and an affiliate real estate investment firm until 1985, when he sold both to a New York Stock Exchange-listed company, staying on as chairman until 1988. In 1989, he formed The Weil Co. (which in 1996 adopted Christopher Weil & Co., Inc. as its ‘dba’) to continue the CWC investor, manager and advisor business. Weil has been in the investment firm business for over 40 years. He is the director of the San Diego Grantmakers, the San Diego Mainly Mozart Festival and the Patricia and Christopher Weil Family Foundation. ALMA MATER: University of California, Los Angeles TRAVELS: Italy AFTER HOURS: His passion is to work to support his philanthropic interests. OUTREACH: The Patricia and Christopher Weil Family Foundation .

Christopher Weil & Co. Investments

1 Investments

Christopher Weil & Co. has made 1 investments. Their latest investment was in Vessix Vascular as part of their Series A on October 10, 2010.

CBI Logo

Christopher Weil & Co. Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

10/26/2010

Series A

Vessix Vascular

$4.7M

Yes

Date

10/26/2010

Round

Series A

Company

Vessix Vascular

Amount

$4.7M

New?

Yes

Co-Investors

Sources

Christopher Weil & Co. Portfolio Exits

1 Portfolio Exit

Christopher Weil & Co. has 1 portfolio exit. Their latest portfolio exit was Vessix Vascular on November 08, 2012.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

11/8/2012

Acquired

$99M

2

Date

11/8/2012

Exit

Acquired

Companies

Valuation

$99M

Acquirer

Sources

2

Christopher Weil & Co. Team

2 Team Members

Christopher Weil & Co. has 2 team members, including current Managing Director, Matthew F. Weil.

Name

Work History

Title

Status

Matthew F. Weil

Managing Director

Current

Gavin Kosviner

Edico Genome, American Assets Trust, First New York Securities, Goldman Sachs, Citigroup, Bankers Trust, and Arthur Andersen

Managing Director

Former

Name

Matthew F. Weil

Gavin Kosviner

Work History

Edico Genome, American Assets Trust, First New York Securities, Goldman Sachs, Citigroup, Bankers Trust, and Arthur Andersen

Title

Managing Director

Managing Director

Status

Current

Former

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.